Hello, Fool! | Login | Signup | My Fool
Dec 4, 2008 7:30 PM ET | Feedback | Site Changes | Help
The Company designs, manufactures, sells and services advanced equipment and software products for treating cancer with radiation.
View All Commentary (VAR)
Recs
ZachGruver (< 20) Submitted: 8/26/08 3:38 PM : Start Price: $62.98 VAR Score: -7.72
Growth is strong, with recent quarterly earnings rising by 49% (.58 versus an estimated .46). The need to treat cancer will increase in the coming decade, and with Varian possessing a 60% share of the worldwide imaging market and a 70% share of the U.S. imaging market it's share price should increase tremendously. Additionally, they have a screener that screens incoming cargo in international ports. Varian has around 350 port screeners installed around the world, but under 30 of them are in the United States. Under 4% of the incoming cargo in the United States is screened, so Varian also has a lot of growth potential surrounding these machines. I think that while Varian currently has a high P/E ratio growth will continue to accelerate, making Varian a very attractive name at these levels.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.